Related Experiment Video
Updated: Feb 7, 2026

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
LRRK2 Kinase Activity Induces Mitochondrial Fission in Microglia via Drp1 and Modulates Neuroinflammation
Dong Hwan Ho1, A Reum Je2, Haejin Lee2
1InAm Neuroscience Research Center, Sanbon Medical Center, College of Medicine, Wonkwang University, Gunpo 15865, Korea.
Abstract:
Leucine-rich repeat kinase 2 (LRRK2) mutations are the most common genetic cause of Parkinson's disease (PD). LRRK2 contains a functional kinase domain and G2019S, the most prevalent LRRK2 pathogenic mutation, increases its kinase activity. LRRK2 regulates mitochondria morphology and autophagy in neurons. LPS treatment increases LRRK2 protein level and mitochondrial fission in microglia, and down-regulation of LRRK2 expression or inhibition of its kinase activity attenuates microglia activation. Here, we evaluated the direct role of LRRK2 G2019S in mitochondrial dynamics in microglia. Initial observation of microglia in G2019S transgenic mice revealed a decrease in mitochondrial area and shortage of microglial processes compared with their littermates. Next, we elucidated the molecular mechanisms of these phenotypes. Treatment of BV2 cells and primary microglia with LPS enhanced mitochondrial fission and increased Drp1, a mitochondrial fission marker, as previously reported. Importantly, both phenotypes were rescued by treatment with GSK2578215A, a LRRK2 kinase inhibitor. Finally, the protein levels of CD68, an active microglia marker, Drp1 and TNF-α were significantly higher in brain lysates of G2019S transgenic mice compared with the levels in their littermates. Taken together, our data suggest that LRRK2 could promote microglial mitochondrial alteration via Drp1 in a kinase-dependent manner, resulting in stimulation of pro-inflammatory responses. This mechanism in microglia might be a potential target to develop PD therapy since neuroinflammation by active microglia is a major symptom of PD.
Insights
Mutations in Leucine-rich repeat kinase 2 (LRRK2) are linked to Parkinson's disease. This study shows that LRRK2 G2019S mutation promotes microglial mitochondrial dysfunction and inflammation, suggesting a therapeutic target for Parkinson's disease.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Leucine-rich repeat kinase 2 (LRRK2) mutations are the most common genetic cause of Parkinson's disease (PD).
- The G2019S mutation increases LRRK2 kinase activity and affects mitochondrial dynamics and autophagy in neurons.
- Microglial activation and neuroinflammation are key features of Parkinson's disease.
Purpose of the Study:
- To investigate the direct role of the LRRK2 G2019S mutation in regulating mitochondrial dynamics within microglia.
- To elucidate the molecular mechanisms underlying LRRK2-mediated microglial dysfunction.
- To assess the potential of targeting LRRK2 kinase activity for Parkinson's disease therapy.
Main Methods:
- Comparative analysis of microglia from G2019S transgenic mice and their littermates.
- In vitro studies using BV2 cells and primary microglia treated with LPS and a LRRK2 kinase inhibitor (GSK2578215A).
- Assessment of mitochondrial morphology, microglial processes, and protein levels of key markers (Drp1, CD68, TNF-α).
Main Results:
- G2019S transgenic mice exhibited reduced mitochondrial area and shorter microglial processes.
- LRRK2 kinase inhibition (GSK2578215A) rescued LPS-induced mitochondrial fission and increased Drp1 levels in microglia.
- Elevated levels of CD68, Drp1, and TNF-α were observed in the brain lysates of G2019S transgenic mice.
Conclusions:
- LRRK2 kinase activity promotes microglial mitochondrial alterations through Drp1, leading to pro-inflammatory responses.
- This LRRK2-dependent mechanism in microglia represents a potential therapeutic target for Parkinson's disease.
- Targeting LRRK2 kinase activity may help mitigate neuroinflammation associated with Parkinson's disease.
More Related Videos
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
08:55Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
Related Concept Videos
Nuclear Fission
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Binary Fission
Binary Fission
Animal Mitochondrial Genetics